Feb. 7, 2013
/PRNewswire/ -- It's no secret that the healthcare landscape is tough and getting tougher. In the U.S., we see the implementation of the healthcare reform against the background of a fragile economic recovery, creating a tumultuous environment for the entire sector.
native and author of
Healthcare at a Turning Point: A Roadmap for Change
will moderate a panel discussion on how recent changes in the legal and regulatory landscape are impacting each sector of the industry at the Wharton Health Care Business Conference on February 15.
Michael will be joined by panelists representing pharmaceuticals, medical devices, payers and healthcare IT to discuss how both domestic and global trends are impacting the entire healthcare sector. This discussion will be followed by a Q&A with Michael and panelists
, PhD, Chief Economist,
, MD, Vice President, Head of US Medical Oncology, Bristol-Myers Squibb,
, President, Regional and Operations, Cigna, and
, MD, President McKesson Health Solutions, McKesson Corporation.
This event is
open to the media.
Annual Wharton Health Care Business Conference Hyatt at the Bellevue
About Michael Abrams
Over the past 25 years, Michael has built a portfolio of strategy and business performance successes as both an internal and external consultant for Fortune 500 corporations on a global basis. Michael is well known for his expertise in the emerging demand for economic and clinical value, and has helped clients develop processes and capabilities to successfully compete in highly dynamic markets. Michael has written extensively on the need for integrated, systemic solutions to the challenges facing the healthcare industry, and has co-authored two books, including
Healthcare at a Turning Point: A Roadmap for Change.
About Numerof & Associates:
NAI is a strategy consulting firm that develops customized, market-based solutions for strategic and operational challenges of organizations in industries undergoing significant transition. Working globally across the healthcare industry with clients in delivery, pharmaceuticals, medical devices and diagnostics, payers, and policy, NAI brings a unique cross-disciplinary approach to a broad range of engagements designed to sharpen strategic focus, increase revenues, reduce costs and risk, and enhance customer value. Visit us at